<SEC-DOCUMENT>0001434265-25-000110.txt : 20251212
<SEC-HEADER>0001434265-25-000110.hdr.sgml : 20251212
<ACCEPTANCE-DATETIME>20251212070008
ACCESSION NUMBER:		0001434265-25-000110
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20251212
FILED AS OF DATE:		20251212
DATE AS OF CHANGE:		20251212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENMAB A/S
		CENTRAL INDEX KEY:			0001434265
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38976
		FILM NUMBER:		251566538

	BUSINESS ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>gmab_20251212x6k.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic90f5852f0b64c5690520b6b0fefbee8_1"></div><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><br>FORM&#160;6-K<br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE&#160;13a-16 OR&#160;15d-16</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE&#160;MONTH OF DECEMBER 2025<br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER 001-38976  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Genmab A&#47;S<br></font><font style="background-color:#ffffff;color:#333333;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Carl Jacobsens Vej 30</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2500 Valby</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denmark</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+45 70 20 27 28<br></font><font style="background-color:#ffffff;color:#333333;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices)<br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or&#160;Form&#160;40-F.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form&#160;20-F&#160;</font><font style="font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      Form&#160;40-F&#160;</font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This report on Form&#160;6-K&#160;shall be deemed to be&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in Genmab A&#47;S&#8217;s registration statements on&#160;Form&#160;S-8&#160;(File&#160;No. 333-232693, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">333-253519, 333-262970, 333-277273 and 333-284876</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">)&#160;and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:3pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;INDEX</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.305%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Exhibit</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="gmab_20251212xex991.htm" style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company Announcement Dated December 12, 2025</a></font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.993%"><tr><td style="width:1.0%"></td><td style="width:48.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.341%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GENMAB A&#47;S</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anthony Pagano</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Anthony Pagano</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Executive Vice President &#38; Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATE&#58; December 12, 2025</font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>gmab_20251212xex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ibb5187fff25844a48245067bb1712933_1"></div><div style="min-height:118.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 99.1</font></div><div style="padding-left:288pt;text-indent:36pt"><font><br></font></div><div style="padding-left:360pt;text-indent:36pt"><img alt="genmab_logo.jpg" src="genmab_logo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period</font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company Announcement</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:13.8pt">Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab&#8217;s portfolio</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:13.8pt">Transaction anticipated to be accretive to Genmab&#8217;s EBITDA by end of 2029</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COPENHAGEN, Denmark&#59; December 12, 2025 &#8211; Genmab A&#47;S (Nasdaq&#58; GMAB) (&#8220;Genmab&#8221;) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the &#8220;Offer&#8221;) by Genmab Holding II B.V., a wholly owned subsidiary of Genmab (&#8220;Purchaser&#8221;), to acquire all the issued and outstanding common shares of Merus N.V. (Nasdaq&#58; MRUS) (&#8220;Merus&#8221;) for $97 per common share in cash have been satisfied. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The transaction meaningfully accelerates Genmab&#8217;s shift to a wholly owned model, expanding and diversifying the company&#8217;s revenue, driving sustained growth into the next decade and contributing to Genmab&#8217;s evolution into a biotechnology leader.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;The Merus acquisition marks a pivotal step in the delivery of Genmab&#8217;s long-term strategy and strengthens our path to becoming a global biotechnology leader with sustained growth and profitability. We are energized by the potential of petosemtamab to meaningfully impact the lives of people with head and neck cancer. Backed by our track record of successful development and commercial execution, we look forward to unlocking petosemtamab&#8217;s full potential and delivering on its promise to patients,&#8221; said Jan van de Winkel, Ph.D., President and Chief Executive Officer of Genmab.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The addition of petosemtamab, Merus&#8217; lead asset, to Genmab&#8217;s promising late-stage pipeline is a compelling strategic fit with Genmab&#8217;s portfolio and aligns with Genmab&#8217;s expertise in antibody therapy development and commercialization in oncology. Based on this successful track record in late-stage development and excellence in commercial execution, Genmab expects to launch petosemtamab in 2027, subject to clinical results and receipt of regulatory approvals. Genmab also intends to broaden and accelerate petosemtamab&#8217;s development with potential expansion into other lines of therapy. Following the initial approval of petosemtamab, Genmab believes that petosemtamab will be accretive to EBITDA with at least one-billion-dollar annual sales potential by 2029, with multi-billion-dollar annual revenue potential thereafter.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At 5&#58;00 p.m. New York City time on December 11, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Expiration Time</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), the Offer and withdrawal rights expired as scheduled. The depositary for the Offer has advised Genmab and Purchaser that, as of the Expiration Time, a total of 71,463,077 of Merus&#8217; issued and outstanding common shares, constituting 94.2% of its issued and outstanding common shares, had been validly tendered pursuant to the Offer and not properly withdrawn.  Effective at 12&#58;01 a.m. New York City time on December 12, 2025, Purchaser accepted for payment, and expects to promptly pay for, all Merus common shares validly tendered and not properly withdrawn pursuant to the Offer.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsequent Offering Period</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Genmab also announced that, as previously disclosed, Purchaser is providing a subsequent offering period of ten business days (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsequent Offering Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), commencing today, December 12, 2025, that will expire at 5&#58;00 p.m., New York City time on December 29, 2025. During the Subsequent Offering Period, Purchaser will offer to purchase additional common shares at the same consideration of $97.00 per share, less any applicable withholding taxes and without interest. All Common shares validly tendered during the Subsequent Offering Period will be immediately accepted and promptly paid for by Purchaser.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following completion of the Subsequent Offering Period, Genmab and Purchaser intend to complete the acquisition of 100% of Merus through a series of previously disclosed back-end transactions. Merus shareholders who do not tender their common shares of Merus in the Offer will receive payment for their </font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Genmab A&#47;S<br>Carl Jacobsens Vej 30<br>2500 Valby, Denmark</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tel&#58; +45 7020 2728<br>www.genmab.com<br></font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company Announcement no. 54</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 1&#47;2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR no. 2102 3884</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LEI Code 529900MTJPDPE4MHJ122</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:118.8pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-left:288pt;text-indent:36pt"><font><br></font></div><div style="padding-left:360pt;text-indent:36pt"><img alt="genmab_logo.jpg" src="genmab_logo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period</font></div><div style="text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">common shares following the completion of these transactions (subject to applicable withholding taxes and without interest).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">About Genmab</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For more than 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab&#8217;s vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.&#8239;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com&#8239;and follow us on LinkedIn and X.   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Contact&#58;            </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Marisol Peron, Senior Vice President, Global Communications &#38; Corporate Affairs</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">T&#58; +1 609 524 0065&#59; E&#58; mmp&#64;genmab.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Andrew Carlsen, Vice President, Head of Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">T&#58; +45 3377 9558&#59; E&#58; acn&#64;genmab.com </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">This Company Announcement contains forward looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend&#8221; and &#8220;plan&#8221; and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with preclinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab&#8217;s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab&#8217;s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">Genmab A&#47;S and&#47;or its subsidiaries own the following trademarks&#58; Genmab</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">&#59; the Y-shaped Genmab logo</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">&#59; Genmab in combination with the Y-shaped Genmab logo</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">&#59; HuMax</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">&#59; DuoBody</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">&#59; HexaBody</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">&#59; DuoHexaBody</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">, HexElect</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">and KYSO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Genmab A&#47;S<br>Carl Jacobsens Vej 30<br>2500 Valby, Denmark</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tel&#58; +45 7020 2728<br>www.genmab.com<br></font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company Announcement no. 54</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 2&#47;2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR no. 2102 3884</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LEI Code 529900MTJPDPE4MHJ122</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>genmab_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 genmab_logo.jpg
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M:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
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M5SB")%4V0U-C<X,9P=&2HC1D)66E*;&RE,34$0$  0(# 0D*"@D# P0" P
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M.GC3_M(%5)6?[34,"[8N6_2B86S(ZKE,]&-B[37R3N\\;8YX9P?)(
M                                 ^==+Q:;'1R7"]72DM%!%_"5M;,R
M")ONOD5J?M@:(OW5+L]8WR10WNIO\T6J.CM=*^1-4[FRS>%&[W4<J!S@P)_6
MC@"/<D>+Y ^-%]!SFTK55/.B5"Z?L@P?6M?6)M=6O;'7T%]LRJNBS34T4L2(
MO?K#,]__ +@,&^\3W$PC.8W/Q3)J*\O8WGDI8G\E0QOUSX)$;*U./:K0X9H
M
M
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MRKH<.W+J6R353VP6G+7<K/3=P9'6Z:)Q71$D1/W?>XY=9A.\.
M
M
M  &)9YE]NP##<ES.[<:'&[?-6R1:Z+*Z-OVN)JZ+HZ1ZM8GG4^EFW-RN*8WY
M86HYZC)9:Y?KV44S/+P1SSN.=;,\NOF>Y3>\PR.J6LO-_JGU59+QY6\W!L<:
M*J\K(VHC&)W-1$+G:MTVZ8IIV0\PY_.W<[?KOW9QJJG&?)'%&R.)C!]&(
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M>RAK9GKJ^:F>BK2RN[U7E:YBJO:K-5XJ<NLI)!P
M
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MUDI-R;Q:U>B07:Q3*L:KIK+3SPO8J)WZ-5_[(<2LR.74
M
M                                                       "$_7S
M:9[EL73UD2*L=@R:WU]3IW,?#4T::_[52TE-(JPO8<,3Y5![1[,W-+BJ/5N4
MS/<JI^LI:+.T.         .A/IVS:?<+9? ,FK9UJ;E-;DHKK.Y=7OJJ![J2
M61^OU4CHN=?=*=G;7LKU5,;,?#NO3'5C4)SVFV;U4XU='">6GS9GGPQYVZC%
M3P                               4H[GY5)FN?Y9DKI?%AN-PE]0=KK
MI2Q+X5,GO1,:<.S PY        ):]'%L?5;FW6XJS6&U6&=5D5-=))IX8V(G
M'@JMY^/F#B5FIRZ@
M
M                           8!NGA$&Y&W>8814.1GY0VV6GI9G=D=2W2
M2FD7S,F8QR^X?;+W?97(KX)1NL:?&?R=W+SZ],Q'+MIGFG"7.=<;?6VBX5]J
MN=,^BN-LJ):2X4<J:/BGA>L<D;D[E:YJHI=*:HJC&-CR]=M56JYHKC"JF9B8
MX)C<F'I'+H        73]!$TLNQ,C)'<S:;)+A'"FB)RM6.G>J<.WTG*O$K&
MKQ_'YH;Y[.*IG2]W>N5>"$UB+7T  ?Q51$5571$[5 ]'Y5M?_$J7^.9_ZP/>
M:YKVM>QR.:Y$5KD75%1>Q44#^@                 #YT]WM-*](ZFZ4E/(
MZ1(D9+/&Q5>O8W1SDX^8#W(9X*AGB4\T<\>NG/&Y')JG=JFH'E   /CY#--3
MV"^3T^J3P6^ID@5.*\[8G*W]M *+3AW         %G'2+@\N/8'6Y16PK%6Y
MG4-EID<FCDH:7F9"NB\4YWND=YV\JG+K*60<
M
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ML@
M
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MXB:(FB(B'+JS(
M
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M37R(SSZG+C%,>WV^@M-%3VZUT4%NM](Q(Z6BIHVQ11M3N:QJ(B)[@</<
M
M
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M(![@
M
M                                   T9U'8K)E>T>30T\?B5ME:R\4C
M435=:->:71$[UA61$\X<PJ(.'8         6R=+5REN&S..QS*KG6NHKJ-KU
M[5:VH?(WO7L21&I[ARZRD,'     /%/,RG@FJ)-?#@C=(_3BNC4U73]@"B:X
M5L]SKZVXU3N>IN%1)4U#_+)*Y7N7]E3AW>F         G3T6XK*^OR_-9HE;
M!!!'9J"54X/?*YM14(GG:C(O_:.765@(<
M
M
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ME(K99*&+GN-6U-/'JY5YYI.*(NBN71NO8U$3N.71GH
M
M
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MH(Y,UKXW,@IT5LC+=3O3BQJIJBRO^K<B\$]%/JE=RZS*4X<
M
M
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M@<N)EO8.
M
M                                                     P7*]LL
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M75555[U.'9X@ &_-H=_LKVPJJ>@GFEOV'.<B55@F?JL#57B^C>[7PW)Q7E^
M[O1%7F0XF%I^,9/9,QL=OR/'JUE?:KE'ST\[>"HJ+HYCVKQ:YJHJ.1>**<NK
M[X'\5$<BM<B.:Y-%1>**B@:3RKIXVDRV26HJ\6BM==+JKJZTO=1.U7M58X_M
M+E7RN8JASBU'6=%V#2.5:#*[[2L5=4;/ZM.J)IQ35L47>#%[%!T8[?0N8ZX9
M)?Z[E3TF1/IH&N77O^T2+IIY%]\&+;^,;![2XF]D]NPZDJZR/14K;DKJY_,G
M8YJ5"O8Q?.UJ Q;A1$:B-:B-:U-$1."(B!P_H
M
M
M                              0]ZK]V9L8LD. 6*I6&]9- LEZJ(UT=
M!;G*K%8BHO!TZHK?W".^N10YA6N<.P    )-=,^[4N!9;%CEUJ=,4RJ9D%0C
MW:,I:QVC8:A->"(JZ,?YM%7X(<3"U Y=0
M
M
M                                >.::*GAEJ)Y&Q0P,=)-*Y=&M:U-7
M*J^1$0"D_<;,*C/,WR/*JASN2ZUCW443M=8Z5GH4\?\ LQM:B^<X=F$AR
M  !<=L9FK\\VQQN]54OC7.GB6WWAZ\7+4TB^&Y[O/(U&R?[1RZ2VX
M
M
M                                                    -3;[7N3'
M]HL]N,3UCD?;'44<B:ZM6O>RD145.**GC<%[@0IN.'<      !8'T47M\ELS
MK&WO^UTE527*EC^RJ&/AF7]B",Y=93G#@
M
M
M                               (V=6,SXMF[I&U$5*FXT$<BKVHB3(_
MA[[$#F%5!P[       )E]%LKTS?+84=]JDL:/>W1.+F5,2-77MX(Y0XE8^<N
MH
M
M                                                           1
M_P"J"WOK]ELJ=&Q'R6^2AJVIIQT95Q->J>31CE7W YA4J<.P      ";?11;
MW29%G5TY?1H[=24JNX\%J9GO1/)Q\!3EUE8>'
M
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MZM=>,SJ>HTV+U-%-%45881..,1TMLS.]$\"QTA6T0
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M90W6CJ':\.&D<KE[SY56+E.VF8YI2%G5LG?]W>MU<E5,^"6;GR2
M
M                                        0-Z^]O8K_MC;,]IH=;G@
ME>QE7*G:MON+FP/1=.WEG\)4\B*[RDMI%[HW)HWJO##77:1ID7\E3F8CSK4[
MOQ:MSZ71[ZG0LK1P!M38Z_KC&\6V=[\18XJ3([>RK>W37U>>=L,^FOEC>XQ\
MU1T[54<4ICJ_F?N^HV+G!73CR3.$]Z9=%)3'IX
M                *K.J/;J7#MPJF_4D"ML.:.?7TTC4]%E9JGK<2^=7KXB>
M9^B=BG#M"- <@    R3$,7N6:9-9<7M$:OKKU5,IXW:*Y(VKQDE>B?4QL17N
M\R*!=;CMBH,8L-GQVUL6.WV6DAHZ1%^$K(6(U'.7O<[355[U.71]D
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MRJJ]B(Y'K]:1&8TZ[9W<,8X8;(T?KGI^I3%,5="N?5KW.Y.R>[CQ)-&"M@
M
M                                          # -UL:;F.V>>XQX22R
M7JPU]-2-7NJ'0/6!R>=LB-5/</MEZ^A<IJX)A&ZSE/O>2O6?A451'+AN=_!S
M@EU>6P#S4U1+25$%5 [DGII&RPO[='L5'-7]E#B8Q=J:IIF)C;#ILH*N.X4-
M%7P_P5;!'41:*B^C(U')Q3@O!2C3&$X/6-NN*Z8JC9,8]U[9P[@
M                           # -S-O;1N;B=?C%V^U.ETFMEP:FKZ6J8B
M^'*WR]JHY.]JJGG I^S/#+_@605N-Y'1.I*^C<O))H[PJB+54;- ]R)SL=IP
M7WET5%0X=F*AR  /)%%)-)'##&Z6:5R,BB8BN<YSET1K43BJJO8@%G_39LC)
MM[:WY5DU,C<POD*-CI'HG-;J1WI>%_WDG!7^31&_7:\NLRE.'
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M5JKHNCDU:[1>5RE<OY>NQ5T:H;NTC6LKJEKVN7JQX8]:F>"J/TB=Z6RSX)4
M
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MEME)!>:R3\ILM8WT+M.Q&0TRKV^JPZNY5TX<[E5WDY454.7&*1 <
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M&/&LO5*QG;NH41E*IIJ]:K>BC?Z4;)CBG;.'*O[*@](@
M
M                           <[6_%*M)O9NU"JH[7+[S*G*FB(DU;+(B>
M\CM"YY2<;-')'@>8NL5'1U/,Q_ZM??JF6IS(0P!T:;-5$E7M!M552Z>+4X?8
MI9.7@G,^WP.71/=4I>9C"[7\:?"]0Z%5-6GY>9W[5'T8;)/@E0
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MHQL>B>J?5VG1\KT:MV[7NUSX*8XJ>_.,I'&$M(
M
M                     '/-U#?3GNQ\Z+C\>XN63]S1R0\R]9OS3,?:5>%I
MLR4& =%NR/T+[0_,JP?@Z I>:]]7\:?"]/\ 5_\ +<M]E;^C#:!\$N
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MZM:]R*Y$7MX)I]XS-R+?L\?-156B9.K-QFYMQ[6/6\<QLF>"9W6RCX)4
M
M                                        !SS=0WTY[L?.BX_'N+ED
M_<T<D/,O6;\TS'VE7A:;,E!@'1;LC]"^T/S*L'X.@*7FO?5_&GPO3_5_\MRW
MV5OZ,-H'P2X                                      :5W<WQQ;:>C
M;%5ZWC):MG/;\<IWHUZM[I)Y-')%'KP15157ZEJZ*J'."NG-^H#=#.)Y?6LB
MGLEL?JC+-9WOI($8OU+W,=XDGGYW*GD1#AS@TS+++/(Z6>5\TKUU?*]RN<J^
M=5XJ'+-<7W+SW#)HI<;RNXVYD2HJ4:3.DIG:=SJ>3FB=[[0X3LV?ZJ[9E-12
MX[N!#3V"]SJV*COD2\E#4O[$;*CU58'KPT756JOUO!%Y<3"8H<
M    (I=86[4FU^TU;2VJK2FRC.'OL]E5JZ210.9K65#/^[B7D14XM>]BDAIN
M7]M=W=D;OD4WKQK4Z=D)IHG"Y<\VGAB/6JYHW.*9A1>6MY[ /8I:6IKJJFHJ
M.!]565DK(*6FB:KGR22.1K&-:G%5<JHB(<3.$8R[4455U133&,SN1'&Z"M@-
MHZ'9G;:S8LR.-U\J&I7997LXK/<)FHLB<VJZMB1$C9]BW7355*?G,Q-^Y-6]
MO<CTKU;T6G2<E39]>=VN>&J=O-&R.*&ZS%3X
M
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M3^%C8Y7QKQ['(BF#<LUV_2B86O)ZEELY3TK%RFN/V9B<.6-L<[+3YLT
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M8Q7*[D=R.1%<B+JB\!F,I<L8=/?=M&ZPY35HK^[S,]"8QQC#;LGDVMP&,FP
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M?77"=]1)R]S6J]5Y6IW(G!.XF:+=-$84QA#66:SE[-5^TO5S75PS.+X!W8P
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M5&D!G-+JM^=;W8X-_P#6V]U;Z_VLY,6<YA1<G95ZE7+\&>]/#&Y"?9$-D
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M.O>=S^-%J?96^"F?.GEJV\T81PXH>N<YSE<Y5<YRZN<O%55>U54DE(VOX
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MD<U*IFLM5EZ^C5S3PO0^@Z[8U?+Q>M;DQN54[],\')P3O\N,1MTQDV
M                  $>>J6N6CV6R6)K^1UQJ*"F1>.JIZW%*Y$5.S5(UUUX
M::H',*FSAV       35Z*JU\>59K;D5?#JK5!4O3NYJ>?D;^U,H<2L5.74
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M<=RN5D-_8YSY5H+@C>5JZKKRQ3M;Z/<UZ*W@CF(6/2LU%5/LYVQLXX:3[0M
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MP4I]=$T3-,[8>D\MF+>8M4W;<XTU1$Q/%+ZYU?<
M  1PZK:5U1LS>Y6ZZ4-;;YWZ)JFBU#(N/DXR(',*I#AV       3.Z+()'9I
ME]4B?:H;*R)Z_925,;F_M,4Y=96.!P          %-GM [IZYO-8[<UZ+':,
M6I&/8BHNDLU552N5=.*:L5G!?=[RRZ/3A9F>&?(T9VE7NGJ-%/P;<=V9JGP8
M(*DLUX 2:Z/+4V[=1.WK)$UAH9*^NDX\=:>@J'QJG_B(TP=2JZ.7JYO"MG4>
MS[76+..R.E/<IG#OX+XRI/10                    "L?KVWKEITH]EL?J
MU8Z>.*XYS+&[1>1VCZ2B71>_1)GIY/#\JH3ND97'^+/-Y6INT;7YIPR%J=N%
M5?U:?K3\GC5=$\U$ 2?Z5MBUWIS[_P"L0O\ R'Q1(ZW)Y&ZM]85SE\"B:Y.*
M+,K55RIV,:[14=RF!J&;]A1N>E.SRK;U/ZO?B^;\^/X5&[5Q\%/RM_BB=_!>
MK145';:.EM]OI8J&@H8F045% QL<444;4:QC&-1$:UJ(B(B)P*I,S,XR]#6[
M=-NF*:8B(B,(B-D0]DX=P   ]*Y6VWWBWUMJNM%#<;9<87T]?05#$DBFBD16
MO8]CD5%147144YIJFF<8VOG=M47:)HKB)IF,)B=DPH<ZG=E%V4W&GM=N;(_$
M<@C6XXG42*KE;"KM):5[E[70/X=JJK%8Y>+BVY#->WMXSMC:\Z];= _",Y-%
M/NZO.HY-^GEIGO83OHY&:JX!;?T ;HRWS%+]M==*CQ*S$'?*./<ZZN6W54BI
M-&GFAG77_P 1$[BNZQE^C5%R-_;RMT]FVKS>L5Y.N=VWYU/Q9G=CFJ^DL.(9
MLT   (K=:E-X_3CG4O/R>I3VB;ETUYM;G2Q:=O#^$U]XD-+G#,4\_@E3^OM'
M2T>]/!-$_OTQXU%9:WGD  9#B^*9'FM[HL<Q2SU-]O=P=RTMOI6<SE\KG*NC
M6-;VN<Y4:U.*JB'2Y<IMT]*J<(9.3R=[-W8M6:9JKG9$?IN1QSN0M4V2Z%,9
MQME'D&[<L667U$;+'BT*K\ETSN"HDSN#JER=Z+I'VIRO3B5_-:M55N6]R.'?
M_4W%H'9Y9R^%W.^?7\"/0CE^%]'BE/ZBH:*VTE/06ZC@M]#2,2*DHJ:-L4,3
M&]C6,8B-:B>1$(B9F9QELBW;IMTQ33$1$;(C<B'M'#N  /0NEKMU[MM?9[O1
MQ7"UW2"2EN%#.WFCFAE:K7L<B]J*BZ'--4TSC&V'SO6:+U$T5QC35&$Q._$N
M?KJ"VM_P?W3R+#Z=9'V9KF5^-SR*JN?052*^)'.73F6->:)SN]S54N&3S'M[
M45;^_P KS7UETC\*SU=B/1VT_%G9W-G+#2QE($ N$]GODC[CM;E&-S/5[\:O
M[I:=%[&4]? Q[6I_XL4B^^5O6*,+L5<,>!N_LTS4W,C<M3ZE?>JB/'$I\D0V
M.    #GDZA&-9OENRC&HQ%RFYN5$31-75#U5??5=5+ED_<T<D/,O6:,-4S'V
ME7A:=,E!@ "<W3YT89'N/'1Y7N&ZJQ'"I>6:BH$:C+E<HUXHYC7HO@1.[4>]
MJN<GP6Z*CR*SFITVO-HW:N]#8/5KJ)>S\1>S6-NUO1Z]?_;''.[.]&^MJPS!
M,0V\LL./878*3'[5#Q6"F9Z4CM-/$FE<JOE>O>Y[E7SE=NW:[L]*J<9;HR&G
M9?(VXM6*(IIXO#,[9GCEEI\V:  -9[M[6X[O!A-TP[(H6HE2U9;3<T:BRT-8
MQ%\*HB7MU:JZ.37TFJK5X*??+YBJQ7%5/_5$ZUH]G5,M58NQMV3OTU;TQ^F[
M&XYX+S::VPWBZV*Y1^#<;+63T%?$G'EGII'12-[NQS50N5-451$QLEYDOV:K
M-RJW7Z5,S$\L3A+YIV?(  ;*VMVGS3>#)(L:PRVK53-Y7W.YRZLHZ&%RZ>+4
MRZ+RIP71$17.[&HJGPS&8HL4]*J?UI72-&S.J7O96*<9WY]6F.&J?TF=Y=/L
M9TT8'LE0Q5-' W(,TFBY;EE]7&WQ=7)H^.D9Z201KY$57+]4YW#2L9O/5YB=
MW<IX&^>KW53*Z13C3'2N[]<[>2GX,=_AF4C#"6@  ?E[&R-<Q[4>QZ*U[')J
MBHO!45%#B8Q4%]4>U]+M1O#?[':J?U7';NR.]8W3HFC8Z6K5W-"U/K8IF21M
MX_!:FO$M^0OS>M1,[8W)><.M^D4Z9J-=NB,**O.IXHJWN:<8CBA'@S%9 +<O
M9WY&^MV_SK%Y).?Y OD-="U5U5D=Q@Y$;IKP3FI7*GG52NZS1A<IJX8\'_5N
MKLQS4UY2]9GU:XGYT?\ XRL+(9LP   /@93C%DS3';QBN1T3;C9+[3/I;A2/
MX<S']BM7M:YJHCFN3BUR(J<4.]NY-NJ*J=L,;.92UF[-5F[&-%483'Z=[@ES
M\;S;3WS9S/;KAEV1U1!&[Q[!=4;HVNH9%7P9FIW.X<KVI\%Z.3BFBK<,MF*;
M]$51S\4O->NZ-=TK-U6*]V-M,_"IG9/BG@G%)O8?HCR;.XZ/)]S)*G#<5F1L
MM)9V-1MUK8UXHJM>BI3L7N5[5>O<Q$5'&#F]4IM^;;W9[WZULZN]0+^=B+V;
MQMV]Z/7J_P"V.7=XM]:9@.UN ;86Y+9@^,4=BB5J-J*N-G/53]G&>IDYI9.*
M:^DY43NT("]F*[TXUSBV_INCY33J.AE[<4\>_/+5.[/=9^?%)      4R]<V
MTEOP/<&VYE8:1M'9=PF3SUE+$U$CBNE.YOK+FHGP4F;(R33O=SK[EFTK,3<M
MS3.VGP-%=H6BT9+-TW[<84W<9F."N/2[N,3RXH.$JU\ 6I>SGR&66R[G8I)(
MO@6^MM]VI(N.G/61RP3KY$X4T?N^\0&M4;M-7+'Z=UN'LOS,S;OV9V1--4?*
MB8GZ,+*R#;5    !SS=0WTY[L?.BX_'N+ED_<T<D/,O6;\TS'VE7A:;,E!@'
MO6VV7&\W"CM5HH9[G<[A*V"AM]+&Z6::1ZZ-8QC$5SE7R(AQ55%,8SL?2U:K
MNUQ11$S5.Y$1NS,K1M@^A>AH8Z/*=ZF-N%P=RRTF!PR:T\/#5/7IHU^VN1?^
MC8O(FGI.>BJU(#-ZM,^;:[OD;=ZN=GM-$1>S^[.];C9'QYC;/%&YPS.Q8]0T
M%#:Z.FMULHX+=;Z.-(J.AIHVPPQ1MX(R.-B(UJ)W(B$+,S,XRVE;MTVZ8IHB
M(B-D1N1')#VSAW   "+_ %!=,.(;TVRKN='!!CVX<$6MLR6-G*VI<Q/1AKVL
M361BIP1^G.SAIJB*QV?D\_78G"=VG@\BH]9>J67U>B:Z8BB]&RKAXJ^&./;'
M>FD#*,9OF&Y!=L6R2WR6N^6.H=2W&AE[6/;Q145.#FN14<UR<'-5'(JHJ%IM
MW*;E,54[L2\_YO*7<I>JLW:>C73.$Q^G>G?C=?!.[' +3?9_[MRU='>]GKQ4
M\SK:Q]XP]7JFJ0/>GKE,W73X+WI*U$U7TI%[$(#6,OA,7(Y)\3;_ &;:U-5-
M>1KG9YU')ZU/=\Z.6I9@0;:X                       UIO'87Y-M;G-G
MBC\:>:U33TL2)JKYJ72IB:GG5\:(@%,!P[@      +$.BNPOI\>S3)9&:-NE
M?3VZG<J<=**-TKU3S*M2B>ZGF.764V@X          "C?K=K/6>H?*8?$1_R
M?06JGY43BSFHHIN5?XW7WRU:7&&7CG\+S[U_KZ6KW(X(IC]V)\:)1(J6 36Z
M"*/UG?:2;E>OR?C=PJ-6)P3FDIX=7\%X?;=/=T(O5YPL<\+[V<4=+5,>"W5/
M?B/&NG*PWR                   !C^69);L.QC(,KNS^2VX[;ZBX5G'159
M3QJ]6MU^J=IHB>53O;HFNJ*8VS+&SN:HREBN]7Z-%,S/-#G&S#*;KF^4W_+K
MY-X]UR*NFKJQVO!KI7*J,9KV-8FC6IW(B(76W;BW3%,;(>7,]G+F<OUW[DXU
M5S,SS^*-D<3&SNQ0"^_I4VVCVUV7Q>CFI_!O>2Q)?\@5R:/\>M8UT<;M4146
M*%(V*GUR.\I4=0O^UO3.]&Y#T;U.TJ-/TVW3,>?7Y]7+5LCFIPCEQ2.,):0
M    (>];N Q9ALI<;Y# DEWP*IBN]'(B:O\ 5GN2"K9KW-\-Z2+_ -VA):7>
MZ%Z(WJMSR*/U_P!-C-:;5<B/.M3%4<FRKO;OR5(A:6@0"1G2?F4F%[\X'5+*
ML=%?ZM;!<6(NB/9<D\")'>9LZQO_ -DPM0M>TL5<6[W%HZFYZ<IJMF=ZJ>A/
MR]R/WL)YE^)47HX   (P=9G^FS<C^Q_PQ0F?IG]13S^"51Z]?DU_Y'TZ5$);
M'G< V/M5M=E&[^8T.&XK UU7.U:BX5TJZ04='&YK9:F94X\K5>U-$XJY4:G%
M3X9B_38HZ524T?2+^J9B+%F-V=V9WJ:=^J?TV[B]'9C8W"MD<>;:<:I4JKO5
ML;^4&43L3UNND;]<NJ^'&U?@1M7E;V\7*YRU3-9NO,58U;-Z.!Z%T'J]EM'L
M]"U&-4^E5/I5>2."G9'+C+<IC)T     "I[VB]I9#EVVM]1BI)<;16T#Y.54
M16T50R5J<W8NBU2\.[7SEAT6KS*HX_T\#37:A9B,Q8N<--4?-F)^LKC)IJX
MM ]F^]RMWD8KE5C5QYS6:\$5WRDBJB>?1"!UOU.?Q-M]EL_U7\OZZST@FVP
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M\B<$575C4L[-VKH4^C'?EOGJ3U8HT^Q3F;L8WJXQ^)3.R(XYCTIYN6:A%KZ
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M10*8MX,'DV]W"R+'$B6.@94+561VBZ.HJA5?#HJ]O(B\BK]<U3AVAK,.0
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M:61T-1"ZV1HYCV*K7-7TNU%30L\:58GA[K0U7:#J],S3,TXQ^S#P_KU[_?\
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MJJX(E(Z/D_OF<LV9V55TQ/)CN]YT?M:UK4:U$:UJ:-:G!$1.Q$0I3U+L?T
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M,1G/))*]7O=RHFKG+Q55XJ5#/S,WZN5Z2ZH44TZ38PC#S<>?&6_C#60
M"L'VD'Z&OSB_%A.Z)Z_-XVI.U/\ M?YGU%8!/-2 %E?LY/ZZW6_F5I^,JB#U
MK91S^)M7LN]YF.2CPU+4B ;A               (:]=K&/V#K7/8USHKY;71
MN5$56NYGMU3R+HJH2>D^_P":5%[1(B=*GX]/C4F%H:# + _9W_2=F_S77^FT
MY#ZS[NGE\3979C_6W?L_K0MZ*XW8    #GFZAOISW8^=%Q^/<7+)^YHY(>9>
MLWYIF/M*O"TV9*# .E7"/^2\0^XEO_HT92+OISRR]5Z?_36_B4^"&4'S98
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M7:";(;[!N+?:56V#'YE6PQR)HE77QKPD3RL@7CKWOT3ZER!Q,K)CEU
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MU)VI_P!K_,^HK )YJ0 L_P#9O_IE_-W\9D#K?J<_B;;[+/[K^7]=9\03;8
M  .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH, Z?2B/6P      #
MGZZG?I]W3^[<GQ;"X9#W%'(\U];?S;,?'\C0YEJZ = W3%] .UGW%C^,>4_/
M^_KY7I3JE^4Y?XGCEO<Q%B      K!]I!^AK\XOQ83NB>OS>-J3M3_M?YGU%
M8!/-2 %E?LY/ZZW6_F5I^,JB#UK91S^)M7LN]YF.2CPU+4B ;A
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MGN#4:J=O+ST2N3SF'-&&9BKAHGO3'E66C-35H5=G'T<Q3/-517XZ%_)4'I$
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M57C1A/1IFK":9W\(G#&*MSD0<_P1WH_RAS7[P7'^0)7[U9^'3W8:^_Q_4O\
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MTJ\+39DH, Z5<(_Y+Q#[B6_^C1E(N^G/++U7I_\ 36_B4^"&4'S98
M!1]UQ4C*;J$R"9FG-<+9:ZB71$3TFTS8>*]_"-.):M*G&Q'++S]V@T13J]<\
M--,][#Q(ADBI0!E='<G18/D5G1WHUU]LU8K>/%:2FND:+VZ</6%[CYS3Y\3Q
M3XF91=PRM='#71/S8KCZSI2*0]5                          ^/>L>L.
M24OJ.0V6AO='Q5M-701U#&JJ:*K4D:NB^=.(&L)>GG9B:1TK\#HD<]=51DM2
MQOO-9*B)[R!SBS/&]NL$Q!Z38UB5KM%2U%:E;!3L]8T7M19W(LBIYN8.&:
M             4Q=?UL6BWNM]:C%1EXQ>AJ/$XZ*^.HJH%35>&J)&FJ)Y4\I
M9M(JQLS'!,^)HGM)M=#4Z:OA6Z9[]4>)!\E6OP"6?1)<6T/4/BE.]6I\K45T
MHT5WE2BEG31=4T5?!T_:([5*<;$\6'A7/J!=Z&KVX^%%4?NS/B7E%5>@P
M        0XZZ_H"N'W;MOQCB2TGW_-*C=H?Y35\>E226EH( L#]G?])V;_-=
M?Z;3D/K/NZ>7Q-E=F/\ 6W?L_K0MZ*XW8  *$NKJ:6HZB]S'RNYWMJJ*-%T1
M/1CM]*QB<-.QK40MVG1AEZ?TWY><NNM4U:Q?QX:>]32C>9JK
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M=S"9WU>A,M9@%E?LY/ZZW6_F5I^,JB#UK91S^)M7LN]YF.2CPU+4B ;A
M!SS=0WTY[L?.BX_'N+ED_<T<D/,O6;\TS'VE7A:;,E!@'2KA'_)>(?<2W_T:
M,I%WTYY9>J]/_IK?Q*?!#*#YLL        I:Z^7L?OI UCVN=%C-O;(U%15:
M[Q:EVB^1=%12SZ1[GGEH?M'F)U2/LZ?#4A.2B@@ #I]*(];
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M 3O]GI]-&3_,JM_"-M(G6?<Q\;Q2V)V9_F5S[*?I4+CBM-Y
M   ",'69_ILW(_L?\,4)GZ9_44\_@E4>O7Y-?^1].E1"6QYW )W^ST^FC)_F
M56_A&VD3K/N8^-XI;$[,_P RN?93]*A<<5IO(      !6#[2#]#7YQ?BPG=$
M]?F\;4G:G_:_S/J*P">:D +/_9O_ *9?S=_&9 ZWZG/XFV^RS^Z_E_76?$$V
MV    #GFZAOISW8^=%Q^/<7+)^YHY(>9>LWYIF/M*O"TV9*# .GTHCUL
M   Y^NIWZ?=T_NW)\6PN&0]Q1R/-?6W\VS'Q_(T.9:N@'0-TQ?0#M9]Q8_C'
ME/S_ +^OE>E.J7Y3E_B>.6]S$6(     "L'VD'Z&OSB_%A.Z)Z_-XVI.U/\
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M:5>%ILR4& =*N$?\EXA]Q+?_ $:,I%WTYY9>J]/_ *:W\2GP0R@^;+
M  *.NN"N;5]0V2P-Y=;9;K73/T[=74D<_'SZ2H6K2HPL1RSX7GWM N=+5[D<
M%-,?NQ/C1')%2P#ZL-"DECN-RY$5:2NHZ9)-5U3UB*J?IIV+KX/;YCK,^=$?
MIO/M3;QM55\$Q'=BKR.F@HSU@
M         ,#W0Q!F?;=YIAKFM=)D-HJJ2C5VB(VI=&JT[^.B>A*C7>\?:Q<]
MG<IJX)1VKY&,[D[MCX=,Q'+AN=R<'.'-#+3S2T\\;H9X'NCFA>FCFO:NCFJB
M]BHJ:%UB<7ENJF:9PG;#Q!P 7C]%.;-R[8JQV^6?Q;CA5346.L:J^DD<;O&I
MET7ZE(96L1?L5\A5=4M="_,[T[KT%U"U#[UI=%,SYUN9HGPT_NS$<R6Q'+H
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MR(534<S-ZY,1Z,;D>5Z%ZDZ%3IN1IKJC^+<B*JN&(]6GFC;QS*5I'KB
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M'BG]F?#":MV,-+N7>&];I[E%R9\,.B$ICTX
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MB/;_ .^PXL/&V/\ A,_XK[3#=]I[3FQ]GX-WOK@BMMW@
M                            !#+K:VFDW VN_*BTTJSY'MXZ2X1LC;S2
M36Z1$2MC31-?01K9?<8Y$XJ2>EYCV=SHSLJ\.\HG7_19SV1]M1&-=K=Y:?6C
MFW*N:5)Y:&A #Z%JNE?8[I;KU:JE]%<[3515ENK(UT?%/ ])(WM\[7-13BJF
M*HF)V2^EF]79KIN43A53,3$\$QNPZ$MD-U;9O%MU8\QH71QU\D:4N1VYB_\
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MB3,1RQN71/28JJUW#M12DW;<VZIIG;$O4V1SE&<L47Z/1KIB8Y][FV,E.C+
M              (P=9G^FS<C^Q_PQ0F?IG]13S^"51Z]?DU_Y'TZ5$);'G<
MG?[/3Z:,G^95;^$;:1.L^YCXWBEL3LS_ #*Y]E/TJ%QQ6F\@      %8/M(/
MT-?G%^+"=T3U^;QM2=J?]K_,^HK )YJ0 L_]F_\ IE_-W\9D#K?J<_B;;[+/
M[K^7]=9\03;8    .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH,
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MVV<S(Q$EDR5&/?WJUE' K4]Y7+^R5S6?>4\GC;K[,8C[E=G?]I]6%@Y#ME@
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M3?;S[;VG'B]-_A%'X=]RWO9]#'Y.&/=W6TS'3
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MT<C%T<Q[5X.:Y$5"J7;55NKHU1A+T-D<]9SMF+UBJ*J)WX\$\$\3)SYLL
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MC&VK<YM]>.H&E3G-1B[5'F6O.GXWJ1W?.^2NW*LW\
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M#GVJ?2R-(@%@?L[_ *3LW^:Z_P!-IR'UGW=/+XFRNS'^MN_9_6A;T5QNP
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M;8    .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH, Z?2B/6P
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MS>DW7M8YJ]Y3<U8FS<FF>;D>G=!U:C5,G1?IVS&%4<%4>E'CCBF);5,=,
M  K:ZNNJ^EMU)=-JMLKFE1=ZE'TF89/3.U921N31])2RM7C*[56R/3@Q-6IZ
M>O)-Z=I\S,7+D;F]'C:KZZ]<J;=-63RE6-4[E=4;T?!IGAX9WMFW95.6!IT
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M<AZ.ZHZ'^%9&FBJ/XE?G5\L[*?DQN<N,[Z1IA+0
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MJ(2V/.X!._V>GTT9/\RJW\(VTB=9]S'QO%+8G9G^97/LI^E0N.*TWD
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M9LXL;%FQ7,XY53TV,I+>]J+YG+<&JO["&/\ @UWAI[_D3$=ING8;MN[W*?\
MO81D_M%K)'#+'AFW-=65#M4@J[U5QTS&>1SH:9)U?[B2-]T^UO1:O6J[B/S?
M:?:B,+%B9GAJF([U../=A"G=+J8W=W;9-0Y#D/R;8)M>;&+.UU'1.1?J941S
MI)D\TKW(G=H2>7R-JSNTQN\,J%J_6O4-3B:;M>%'P:?-IY]^KY4RT$9BM@ "
MP_HEZ>)\BO%)O!E]"K<<L<RNPVBF;PK:Z-=/6M%[8Z=R>BOU4G[A46&U3.=&
M/9T[9V\4?K;-Z@]6)OW(SU^/,IGS(GUJOA<E.]PU<BVXKK=(
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MU)VI_P!K_,^HK )YJ0 L_P#9O_IE_-W\9D#K?J<_B;;[+/[K^7]=9\03;8
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M,,349'&QC=$:UK41$1"LS,U3C.UO6U:IM4111$13$81$;(B-D/<.'<
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MV,_9O;)PG@EIK5NJ&HZ=,S7;FJCX5'G1S[]//$(\JBHJHJ:*G!44S%9?P
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MEH+A3R4TS53@NL<K6N3]@E*:Z:HQIG&%"OY:[EZNA=IFFK@F)B>Y+Y!V?$
M;?V^V&W9W.D@7$L+KZFWSZ*E]JF>J6]&KVN2IGY&/T3CHQ7.\QC7LW:M>E5N
M\&^F],ZN9_49CV-J9IGUI\VGYT[D\V,K*ME>AG$,+EI;_N7509UD,*MD@LS&
M*EHIWI]<R1$=4JB]BO1K?+&O:0F:U6NYN4;D=_\ 4VKH/9[E\I,7,W,7*_@^
MI'_=SX1^RGDQC8VM8QJ,8Q$:QC4T1$3@B(B$0V+$8/T'(
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M(/R=S?;/D'U7P.;S^J^CJ8%SIX^?CCQK?DONO1_VW0Z/[&&'[K+3YLT
M
M  $?MSOU9?6)O\5/R#^5?2\7Y4]2^4OLM-/]Y]W3O,RQ]Y__ (^EAQ8X>16M
M6_!<9^^>QZ7[71Z?_<B)D/\ Y='/+S<OK7,G-\D_E%RZ:_4\OVC3RZ$C1^(?
M]>BI69_P_'C_ &?:_P#ZL4__ %W_ /WO_P#.'T_W_%WF'_\ 4/V__D;)P_\
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M;V$8X?M8=[F:^ZB_AOXI7T>ECA_"Z>&/[6S<Z6&SBZ6^MV*XW6
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* 6^']     #_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
